Bd introduces smart connected robotics to automate microbial identification

Franklin lakes, n.j., jan. 7, 2022 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that it has received 510(k) clearance from the u.s. food and drug administration (fda) for the bd kiestra™ identifa system, which is designed to automate the preparation of microbiology bacterial identification testing.
BDX Ratings Summary
BDX Quant Ranking